Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT05886517

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
AUSL Romagna Rimini (from the registry)
Registry
  • NCT NCT05886517
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05886517. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-01 (actual); primary completion 2026-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
Condition
Aortic Stenosis
Intervention (Device)
Transfemoral transcatheter aortic valve implementation
Lead sponsor
AUSL Romagna Rimini (class: other)

Record details

Record id
cardio:ct-nct05886517
Content hash
a8d1822f745c9540bcd4f4bd87b1908e6f697260898d1db5e67c78a7ae2d16fb